Pall

Contact
fortebio.com
+16503221360

Pall ForteBio Corp.

Menlo Science & Technology Park 1360 Willow Road, Suite 201
94025 Menlo Park
USA

Phone

fortebio.com
Contact
Profile Products News
Contact

About Pall

ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.

Read more about Pall
Facts about Pall
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of Pall

Product portfolio

Show all

News about Pall

Pall

02-May-2023 | business & finance

Pall and Cytiva join forces

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

Read news
Pall

03-Aug-2021 | business & finance

Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand.

Read news
Pall

26-May-2015 | business & finance

Danaher To Acquire Pall Corporation

Danaher Corporation announced that it has entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher will acquire all of ...

Read news
Pall

05-May-2014 | business & finance

Pall Corp. Acquires Filter Specialists Inc.

Pall Corporation announced it has acquired Filter Specialists Inc. (FSI), a worldwide supplier of filtration products and solutions based in Michigan City ...

Read news
Pall

20-Feb-2014 | business & finance

Pall Corp. Completes Acquisition of ATMI LifeSciences

Pall Corporation announced it has completed the acquisition of the LifeSciences business of ATMI, Inc.. The ATMI LifeSciences portfolio acquired by Pall ...

Read news
Pall

23-Dec-2013 | business & finance

Pall Corp. Signs Agreement to Acquire ATMI’s LifeSciences Business

Pall Corporation announced it has entered into a definitive agreement with ATMI, Inc. to acquire the ATMI LifeSciences business for $185 million. ATMI ...

Read news
Pall

15-Oct-2013 | business & finance

Pall Opens New Life Sciences Centre of Excellence in Shanghai

Pall Corporation inaugurated the Pall Life Sciences Centre of Excellence (CoE) at its new Zhangjiang site in Shanghai in the People’s Republic of China. ...

Read news
Pall

04-Apr-2013 | business & finance

Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth

Pall Corporation confirmed plans for a state-of–the-art Life Sciences Centre of Excellence at its new Harbourgate site in Portsmouth in the United Kingdom ...

Read news
Show more news about Pall

Here you will find Pall ForteBio Corp.

Last viewed contents

Memo Therapeutics AG - Schlieren, Switzerland

Memo Therapeutics AG - Schlieren, Switzerland

Go to page
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Go to page
Becton Dickinson International – Branch of Becton Dickinson B.V. - Erembodegem, Belgium

Becton Dickinson International – Branch of Becton Dickinson B.V. - Erembodegem, Belgium

Go to page